5 completed. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
| Phase 2 | 1 | Completed 1 |
Follow Dermatitis, Allergic Contact: new trials by email Literature Review of Dermatitis, Allergic Contact trials Research Report on Dermatitis, Allergic Contact
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Potential Development of Photoallergic Skin Reaction After Use of MC2-01 Cream Induction: Application of MC2-01 Cream, irradiation, Induction: Application of MC2-01 Cream, no irradiation, Induction: Applications of MC2-01 vehicle, irradiation - Photoallergy | Phase 1 | Completed | MC2 Therapeutics | 58 | 2019-02-13 | 2020-03-11 |
| Effect of RANKL Inhibition on UV-induced Immunosuppression Denosumab, UVB exposure, Diphenylcyclopropenone - Ultraviolet Rays, Immunosuppression | Phase 1 | Completed | Innovaderm Research Inc. | 31 | 2013-11-01 | 2014-07-24 |
| Safety, Tolerability, and Efficacy of 21 Days Dermal Application of MRX-6 on Mild to Moderate Contact Dermatitis MRX-6, Steroid - Allergic Contact Dermatitis | Phase 1 / Phase 2 | Completed | Hadassah Medical Organization | 13 | 2011-03-01 | 2015-04-21 |
| CP-481,715 Nickel Allergy Study. CP-481,715 - Dermatitis, Allergic Contact | Phase 1 | Completed | Pfizer | 48 | 2003-09-01 | 2006-07-25 |
| NI-0801 in Allergic Contact Dermatitis Placebo, NI-0801 - Allergic Contact Dermatitis | Phase 1 | Completed | Light Chain Bioscience - Novimmune SA | 22 | 2010-11-19 |
Dermatitis, Contact (1) · Dermatitis, Photoallergic (1) · Eczema (1) · Hypersensitivity, Delayed (1)
Dermatitis (5) · Hypersensitivity (5) · Immune System Diseases (5) · Skin Diseases (5) · Skin Diseases, Eczematous (5) · Skin and Connective Tissue Diseases (5) · Dermatitis, Contact (4) · Hypersensitivity, Delayed (4) · Photosensitivity Disorders (1)
Denosumab (1) · Radiation (1) · RulB protein, Pseudomonas syringae (1) · Saline Solution (1) · Sodium Chloride (1) · Steroids (1) · diphenylcyclopropenone (1) · quinoxaline-2-carboxylic acid (4-carbamoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyloctyl)amide (1)
Hadassah Medical Organization (1) · Innovaderm Research Inc. (1) · Light Chain Bioscience - Novimmune SA (1) · MC2 Therapeutics (1) · Pfizer (1)
United States (2) · Canada (1) · Denmark (1) · Israel (1)
Jonathan S Dosik, MD (1) · Robert Bissonnette, MD (1) · Yuval Ramot, MD (1)